0

Global Burkitt Lymphoma Therapeutics Market 2018-2022

  • Published: Sep 2018
  • Pages: 111
  • SKU: IRTNTR23697
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

Technavio’s market research analysts have predicted that the Burkitt lymphoma market will register a revenue of more than USD 730 million by 2022. This industry research report presents a comprehensive analysis of the global Burkitt lymphoma market by drug class such as biological and small molecules. The report also presents a detailed analysis of the market’s growth prospects across the world.

Highlights of the Burkitt lymphoma market research report are​

 

Global Burkitt lymphoma industry insights

Our analysts have identified the rising progression of Burkitt lymphoma to be one of the major factors driving market growth. Burkitt lymphoma is recognized as one of the most fatal and fastest growing tumors in humans. This disease weakens the immunity and leads to several kinds of diseases as the body loses its ability to keep the natural defense system healthy. Burkitt lymphoma needs to be treated immediately as it is fatal, and this factor is motivating the companies to invest heavily in R&D to develop therapies that are highly effective. Several companies are developing various therapies to neutralize Burkitt Lymphoma. The rapid rise of this disease has compelled the companies to develop a drug for the disease and this factor will propel the Burkitt lymphoma market growth.                                          

                                       

Want a bigger picture? Try a FREE sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report. 

 

Burkitt lymphoma market report: Companies covered

The Burkitt lymphoma market is moderately concentrated owing to the presence of a few vendors. This Burkitt lymphoma industry analysis report will help the clients identify new growth opportunities and design new growth strategies. Also, this report offers a competitive analysis of the players in the Burkitt lymphoma market along with information on the products offered by the companies.

The report offers a complete analysis of a number of companies including:

  • Biogen
  • F. Hoffmann-La Roche
  • Merck Sharp & Dohme
  • Novartis
  • Spectrum Pharmaceuticals

 

Get more value with Technavio’s subscription platform! Gain easy access to all of Technavio’s reports, along with on-demand services. Try the demo

 

Burkitt lymphoma market growth based on geographic regions

  • Americas
  • APAC
  • EMEA

In terms of geographic regions, the Americas accounted for the major share in the market in 2017. Maximum revenue is generated from countries such as the US and Canada which is propelling the growth of the market.

Key highlights of the global Burkitt lymphoma market for the forecast years 2018-2022:

  • CAGR of the Burkitt lymphoma market during the forecast period 2018-2022
  • Detailed information on factors that will accelerate the growth of the Burkitt lymphoma market during the next five years
  • Precise estimation of the global Burkitt lymphoma market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the Burkitt lymphoma industry across various geographies such as the Americas, APAC, and EMEA
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive information about factors that will challenge the growth of Burkitt lymphoma manufacturers

 

Want to dial in on a specific region or segment? We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: DISEASE OVERVIEW

  • Burkitt lymphoma

PART 05: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 06: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 07: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 08: PIPELINE

PART 09: MARKET SEGMENTATION BY DRUG CLASS

  • Segmentation by drug class
  • Comparison by drug class
  • Biological – Market size and forecast 2017-2022
  • Small molecule – Market size and forecast 2017-2022
  • Market opportunity by drug class

PART 10: CUSTOMER LANDSCAPE

PART 11: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas – Market size and forecast 2017-2022
  • EMEA – Market size and forecast 2017-2022
  • APAC – Market size and forecast 2017-2022
  • Key leading countries
  • Market opportunity

PART 12: DECISION FRAMEWORK

PART 13: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 14: MARKET TRENDS

PART 15: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 16: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Biogen
  • F. Hoffmann-La Roche
  • Merck Sharp & Dohme
  • Novartis
  • Spectrum Pharmaceuticals

PART 17: APPENDIX

  • List of abbreviations

PART 18: EXPLORE TECHNAVIO 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>